|Articles|August 4, 2004
Scott Whitcup, MD, leads Allergan R&D efforts; Schultz oversees U.S. business unit
Allergan Inc. announces the appointment of Scott Whitcup, MD, to executive vice president, research and development, and Joseph Schultz to senior vice president of Allergan's U.S. ophthalmology business unit.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
First patient treated in ViaLase’s IDE trial
2
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
3
Formosa Pharmaceuticals and Rxilient sign licensing and commercialization agreement for APP13007
4
PainReform launches development plan for OcuRing-K, readies phase 2 trial
5











































.png)


